
Power List kudos for Kiwis
New Zealand’s Professor Helen Danesh-Meyer and Dr Ben LaHood have been named in The Ophthalmologist’s 2023 Power List. The annual list celebrates the most influential figures in ophthalmology from all around the world.
4293 articles

New Zealand’s Professor Helen Danesh-Meyer and Dr Ben LaHood have been named in The Ophthalmologist’s 2023 Power List. The annual list celebrates the most influential figures in ophthalmology from all around the world.

Returning after a five-year hiatus, The Orthokeratology Society of Oceania (OSO) is putting on its largest conference to date running from 1-3 September at the JW Marriott Gold Coast Resort and Spa.

Matthews Eyewear Eyecare has acquired Fiordland Eyecare, with Fiordland’s Te Anau and Invercargill clinics continuing to trade as Southland Eyecare.

Skye Cappuccio, interim CEO at Optometry Australia (OA) since October 2022, has been confirmed as permanent CEO. With a strong background in advocacy and policy and with more than 10 years with OA,

Long-time International Opticians’ Association (IOA) president Fiona Anderson handed over the presidency baton at the inaugural Silmo Singapore event to Auckland-based Donald Crichton, a fellow of the Association of British Dispensing Opticians and former president of the Association of Dispensing O

Former acting CEO Amanda Trotman is the new CEO for the Optical Distributors and Manufacturers Association (ODMA).

An artificial intelligence (AI) tool was found to be as effective as senior paediatric ophthalmologists in discriminating normal retinal images from those with retinopathy of prematurity (ROP),

A new class of therapeutics which activate intrinsic biological stress-resilience mechanisms could be used to treat age-related and inherited retinal diseases, said US researchers.

OliX Pharmaceuticals has treated the first patients in its phase 1 clinical trial evaluating OLX10212, an investigational RNA interference-based gene-silencing (siRNA) therapeutic for the treatment of

Miebo, a single-ingredient tear stabiliser from Bausch + Lomb and Novaliq, has been given the green light by the US Food and Drug Administration (FDA), offering a new treatment for dry eye disease

A new survey is seeking to recommend charge-out rates based on operating expenses for New Zealand optometry practices.

US doctoral student Ruidong Zhang has developed spectacle frames capable of reading lip and mouth movements to infer speech, providing a hands- and eyes-free input method for a variety of applications.